We should make off-label research publicly available in a non-promotional format to both healthcare professionals and patients.
Data analytics, relationship building, and improved patient support are the keys to differentiating your rare-disease drug brands, according to these four marketers.
Does virtual reality represent a new way for marketers to create immersive experiences — or is this just the industry's latest shiny object?
Pharma must be thoughtful in its approach and demonstrate value to be part of the EHR conversation.
It's been called "America's other drug problem."
Pharma marketing has long been deemed slow to adapt. Last weekend's Lions Health festival offered a glimpse of healthcare as a first mover.
The traditional line of attack is genuine and requires little in the way of spin—yet still, every time a Turing rears its head, it gets blown back in small and indigestible pieces.
If more physicians begin participating in late-phase research efforts—and work to educate patients about these opportunities—we can expect new innovations in treatment solutions to come more quickly to market.
There is an immediate need for greater education regarding halal and vaccines for Muslim consumers worldwide.
Although the industry wants to help patients get healthy - and wants to be a critical part in that process - there's a delicate balance to strike between selling product and achieving healthier outcomes.
We need to view the patient journey as a starting place for much deeper analysis.
When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.
Why healthcare brands need to start speaking in video, and how they can do it
Agencies struggle to find VPs of digital strategy (or multichannel strategy or engagement strategy) because they don't really need one.
"In this fast-moving environment, we believe these five guidelines will help guide your clinical trial team in taking full advantage of this exciting new platform."
The healthcare ecosystem is changing rapidly to succeed requires the adoption of key account management (KAM), a systematic, robust alternative to the traditional buyer/seller model.
How the adoption of principles from recent, successful start ups can be applied to pharma marketing.
Key trends from the latest Consumer Electronics Show through the eyes of NostaLab's John Nosta
"Although the United States represents almost half of the biologics market in terms of revenue and volume, biosimilars growth will be fueled by focusing on the emerging markets, by addressing non-consumption and patient inability to pay for high-priced biologics."
"The trouble is that the market is changing much faster than most marketers realize."
"Customer service is more than just a nice-to-have. In this competitive marketplace, it can mean the difference between your brand or someone else's."
"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."
- Lilly's branded app for Trulicity looks to address adherence
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Wednesday, November 30, 2016
- Five things for pharma marketers to know: Monday, December 5, 2016
- Five things for pharma marketers to know: Thursday, December 1, 2016
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials
- BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
- Five things for pharma marketers to know: Tuesday, December 6, 2016
- Rock Health's Bill Evans on finding a career with meaning
- Matt Brown leaves Guidemark Health after merger falls through